Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04728828Completed

COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients

Role: collaborator

NCT02098252Not ApplicableRecruiting

Treatment of Brain AVMs (TOBAS) Study

Role: collaborator

NCT03562052Recruiting

Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens

Role: collaborator

NCT05953558Recruiting

French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV

Role: collaborator

NCT05302115Unknown

S-ICD French Cohort Study (HONEST)

Role: collaborator

NCT04363593Not ApplicableCompleted

Serology COVID-19 From the Cornwall Hospital Union

Role: collaborator

NCT02904005Not ApplicableUnknown

Predictors of Suicidal Behavior in Depression

Role: collaborator

NCT00967304Phase 4Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Role: collaborator

NCT01722617Not ApplicableCompleted

A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.

Role: collaborator

All 9 trials loaded